Abbott Laboratories
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $10.59B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.81B | 17.1% |
| Other Investing | $118.3M | 1.1% |
| Dividends Paid | $3.20B | 30.2% |
| Stock Repurchases | $2.30B | 21.7% |
| Net Change in Short-Term Borrowings | $203.9M | 1.9% |
| Net Cash Flow | $2.96B | 28.0% |